Caricamento...
Off-label use of orphan medicinal products: a Belgian qualitative study
BACKGROUND: Off-label use of (orphan) medicinal products for (rare) diseases is quite common but not underpinned by clinical studies to confirm efficacy and safety. No risk-analyses by regulatory agencies are carried out. The objective of this study was to map off-label use of orphan medicinal produ...
Salvato in:
| Pubblicato in: | Orphanet J Rare Dis |
|---|---|
| Autori principali: | , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
BioMed Central
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5086036/ https://ncbi.nlm.nih.gov/pubmed/27793155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13023-016-0507-y |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|